CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for ApicHope Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

ApicHope Pharmaceutical Co Ltd
17-19F, Yunrun Mansion, No.27 Huanyu 1st
Guangzhou International Biological Islan
Phone: +86 2028877623p:+86 2028877623 GUANGZHOU, GNG  510320  China Ticker: 300723300723
Business Summary
ApicHope Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development, production and sales of drugs. The Company has two types of products which are children's drugs and chronic disease drugs. The children's drugs are used for the treatment of colds, digestive anorexia, viral infections, children's eczema and other diseases, including clindamycin palmitate dispersible tablets and clindamycin palmitate granules. The chronic disease drugs include hepatocyte growth-promoting hormone for injection, aceglutamine for injection and adenosine cyclophosphate for injection, which are used for the treatment of severe viral hepatitis and cardiovascular and cerebrovascular diseases. The Company is also engaged in selling drugs for agents.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager, Acting Secretary of the Board HanxiongLi 48 6/7/2022 11/27/2018
Chief Financial Officer HuixingZhang 56 12/7/2021 12/7/2021
Deputy General Manager, Director DonglingYang 54 12/7/2021 12/7/2021
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 1,386 (As of 12/31/2022)
Outstanding Shares: 454,143,281 (As of 9/30/2023)
Shareholders: 10,214
Stock Exchange: SHE
Fax Number: +86 2028877668


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024